Abstract
Objective To observe the efficacy,toxicity and influence on quality of Life (QOL) of Kang'ai injection combined with gemcitabine for elderly patients with advanced stage non-small cell lung cancer.Methods Fifty-eight patients with advanced non-small cell lung cancer were randomly divided into two groups:treatment group (n =30) received Kang' ai injection and chemotherapy,and control group (n =28) only accepted chemotherapy.Results The effective rates of treatment and control group were 35.7％ (10/28) and 32.1％ (9/28),the difference between the two groups was not significant (P ＞ 0.05).The toxicity was lower in treatment group than that in the control group (P ＜0.05),and the QOL was improved significantly (P ＜ 0.05).Conclusions In treatment of elderly patients with advanced stage non-small cell lung cancer,Kang' ai injection combined with chemotherapy can improve the effect,reduce the toxicity and improve the QOL. Key words: Kang' ai injection; Non-small cell lung cancer; Chemotherapy; Quality of life
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
